Telomir Pharmaceuticals, Inc. (TELO): SCHEDULE 13G/A filed Feb 12, 2026

Form type

SCHEDULE 13G/A

Filing date

Feb 12, 2026

Accession number

0001104659-26-014568

Filer

Telomir Pharmaceuticals, Inc. (CIK 1971532)